Unlock instant, AI-driven research and patent intelligence for your innovation.

Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same

a technology of polyester amide and polymer, which is applied in the field of polyester amide and agent for use with medical articles, can solve the problems of insufficient hardness of currently available polyester amide, insufficient mechanical properties of polyester amide for many stent applications, and the possibility of binding of molecules from the polymeric carrier to the agen

Inactive Publication Date: 2005-12-01
ABBOTT CARDIOVASCULAR
View PDF99 Cites 104 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention relates to polymers containing poly(ester amides) and agents for use in medical articles. The polymers are made by a reaction between a polyol, a polycarboxylic acid, an amino acid, and a straight-chained or branched, cyclic or unsaturated aliphatic or hetero-aromatic radical. The polymers can also contain other groups such as hydrogen, straight-chained or branched saturated or unsaturated aliphatic or hetero-aromatic radicals, or cyclic or unsaturated aliphatic or hetero-aromatic rings. The polymers can be used to make various medical articles such as catheters, stents, and implants. The invention also includes methods for fabricating the polymers and the use of the polymers in medical articles.

Problems solved by technology

Uncontrolled protein adsorption on an implant surface is a problem with current biomaterial implants and leads to a mixed layer of partially denatured proteins on the implant surface.
Problems with PTCA include formation of intimal flaps or torn arterial linings, both of which can create another occlusion in the lumen of the coronary artery.
Moreover, thrombosis and restenosis may occur several months after the procedure and create a need for additional angioplasty or a surgical by-pass operation.
Local delivery of agents is often preferred over systemic delivery of agents, particularly where high systemic doses are necessary to achieve an effect at a particular site within a mammal, because high systemic doses of agent can often create adverse effects within the mammal.
Some of the currently desired polymeric materials are biodegradable but, unfortunately, these polymers do not have sufficient mechanical properties for a number of medical applications.
For example, the hardness of currently available poly(ester amides) has been found to be insufficient for many stent applications.
Another problem involves regulatory concerns associated with the release of agents from biodegradable coatings within a mammal.
The problem is that molecules from the polymeric carrier may be attached to the agent upon breakdown of the coating.
Since these additional molecules were not considered in the original regulatory approval of the agent, there may be regulatory concerns over possible changes in the agent's biological activity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same
  • Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same
  • Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0105] The PEA of formula (XVII) can be prepared according to the following procedure:

Method of preparing of L-Leucine-ε-L-Lysine Benzyl Ester-2TosOH

[0106] L-leucine-ε-L-lysine HCl (New England Peptide, Inc.) (73.86 gm, 0.25 mole), p-toluenesulfonic acid (152.15 gm, 0.80 mole), benzyl alcohol (100.9 ml, 0.97 mole), and 200 ml of benzene is added to a 1 liter reaction flask equipped with a mechanical stirrer, Dean Stark trap, thermometer and argon inlet. The mixture is heated to 80° C. for 8 hours, and condensate is collected in the Dean Stark trap. The mixture is transferred to a 2 liter flask, and 1 liter of ethyl acetate is added to the mixture with stirring. The mixture is stored overnight at 4° C., and L-Leucine-ε-L-Lysine Benzyl Ester-2TosOH and is isolated by filtration.

Method of preparing co-poly-{[N,N′-sebacoyl-bis-(L-leucine)-1,6-hexylene diester]-[N,N′-sebacoyl-L-leucine-L-lysine mPEG amide]}

[0107] Dry triethylamine (61.6 ml, 0.44 mole) is added to a mixture of di-p-tol...

example 2

[0109] The copolymer represented by formula (XII) can be prepared in a manner analogous to the method used to prepare the copolymer represented by formula (XVII) by replacing the L-leucine-ε-L-lysine-HCl with L-lysine HCl. While not intending to be bound by any theory or mechanism of action, a proposed reaction mechanism for the preparation of the PEA of formula (XII) according to one embodiment of the present invention is illustrated in FIG. 2.

example 3

[0110] The PEA of formula (XV) can be prepared according to the following procedure:

Method of preparing co-poly-{[N,N′-sebacoyl-bis-(L-leucine)-1,4-butylene diester]-[N,N′-sebacoyl-L-lysine-4-carboxy-TEMPO anhydride]}

[0111] Dry triethylamine (61.6 ml, 0.44 mole) is added to a mixture of a di-p-toluenesulfonic acid salt of bis-(L-leucine)-1,4-butylene diester (118.82 gm, 0.18 mole), a di-p-toluenesulfonic acid salt of L-lysine benzyl ester (11.603 gm, 0.02 mole), and di-p-nitrophenyl sebacinate (88.88 gm, 0.2 mole) in dry DMAC (110 ml). The mixture is stirred and heated at 80° C. for 12 hours, cooled to room temperature, diluted with ethanol (300 ml), and poured into water (1 liter). The polymer is separated, washed with water, and dried under vacuum. A free carboxyl group can be generated by hydrogenolysis over a palladium catalyst. Ethanol (1200 ml) is combined with the polymer (100 gm) and a palladium on carbon catalyst in a 2 liter flask (Aldrich). Hydrogen is bubbled and stirre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same are disclosed. The medical article generally comprises an implantable substrate having a coating, and the coating contains a polymer comprising a polymeric product of a reaction comprising a polyol, a polycarboxylic acid, an amino acid and an agent.

Description

BACKGROUND [0001] 1. Field of the Invention [0002] This invention is directed to polymers for use with medical articles and, more specifically, polymers containing poly(ester amides) and agents. [0003] 2. Description of the State of the Art [0004] A current paradigm in biomaterials research is the control of protein adsorption on an implant surface. Uncontrolled protein adsorption on an implant surface is a problem with current biomaterial implants and leads to a mixed layer of partially denatured proteins on the implant surface. This mixed layer of partially denatured proteins leads to disease, for example, by providing cell-binding sites from adsorbed plasma proteins such as fibrinogen and immunoglobulin G. Platelets and inflammatory cells such as, for example, monocytes, macrophages and neutrophils, adhere to the cell-binding sites. A wide variety of proinflammatory and proliferative factors may be secreted and result in a diseased state. Accordingly, a non-fouling surface, which...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61L27/34A61L29/08A61L31/10C08G69/44
CPCA61L31/10C08G69/44C08L77/12A61P35/00A61P39/06A61P41/00A61P5/30A61P7/02
Inventor PACETTI, STEPHEN D.CLAUDE, CHARLESGLAUSER, THIERRYDESNOYER, JESSICA R.HOSSAINY, SYED F.A.
Owner ABBOTT CARDIOVASCULAR